EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes

Kwadwo Fosu, Jude Tetteh Quarshie, Kwabena Amofa Nketia Sarpong, Anastasia Rosebud Aikins iD

Genes · 26.03.2023 · 14 (4) · 800

DOI: 10.3390/genes14040800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 26.03.2023. Verfasst von Kwadwo Fosu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 54, Ghana. Hauptthemen laut MEDLINE: Down Syndrome, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Bank African Centres of Excellence Impact.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An inverse comorbidity has been observed between Down syndrome (DS) and solid tumors such as breast and lung cancers, and it is posited that the overexpression of genes within the Down Syndrome Critical Region (DSCR) of human chromosome 21 may account for this phenomenon. By analyzing publicly available DS mouse model transcriptomics data, we aimed to identify DSCR genes that may protect against human breast and lung cancers. Gene expression analyses with GEPIA2 and UALCAN showed that DSCR genes ETS2 and RCAN1 are significantly downregulated in breast and lung cancers, and their expression levels are higher in triple-negative compared to luminal and HER2-positive breast cancers. KM Plotter showed that low levels of ETS2 and RCAN1 are associated with poor survival outcomes in breast and lung cancers. Correlation analyses using OncoDB revealed that both genes are positively correlated in breast and lung cancers, suggesting that they are co-expressed and perhaps have complementary functions. Functional enrichment analyses using LinkedOmics also demonstrated that ETS2 and RCAN1 expression correlates with T-cell receptor signaling, regulation of immunological synapses, TGF-β signaling, EGFR signaling, IFN-γ signaling, TNF signaling, angiogenesis, and the p53 pathway. Altogether, ETS2 and RCAN1 may be essential for the development of breast and lung cancers. Experimental validation of their biological functions may further unravel their roles in DS and breast and lung cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeLung NeoplasmsMiceAnimalsHumansTranscription FactorsSignal Transduction

Stichwörter der Autor:innen

ETS2RCAN1breast cancerdown syndromelung cancer

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Department of Biochemistry Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 54, Ghana.
  • West African Centre for Cell Biology of Infectious Pathogens, Legon, Accra P.O. Box LG 54, Ghana.

ORCID-Profile: Anastasia Rosebud Aikins

Förderung

  • World Bank African Centres of Excellence Impact

Zitieren

APA

Fosu, K., Quarshie, J. T., Sarpong, K. A. N., & Aikins, A. R. (2023). Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes. Genes, 14(4), 800. https://doi.org/10.3390/genes14040800

Vancouver

Fosu K, Quarshie JT, Sarpong KAN, Aikins AR. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes. Genes. 2023;14(4):800. doi:10.3390/genes14040800

BibTeX
@article{Fosu2023,
  author = {Fosu, Kwadwo and Quarshie, Jude Tetteh and Sarpong, Kwabena Amofa Nketia and Aikins, Anastasia Rosebud},
  title = {Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {4},
  pages = {800},
  doi = {10.3390/genes14040800}
}
Kostenlos starten →